Hanmi Pharm rises to 'large-cap' shares: KRX
SEOUL, March 12 (Yonhap) -- South Korea's main bourse operator Korea Exchange (KRX) said Saturday that leading drugmaker Hanmi Pharmaceutical Co. has grown to become one of the bourse's "large-cap" shares, while other traditionally top players such as shipbuilders lost ground.
The KRX said according to its calculation of share prices over the December-February period, 12 firms, including Hanmi, grew from mid-bracket to large-cap over the cited period.
The bourse operator categorizes the top 100 firms in terms of market capitalization as large-cap, while the next 200 companies are defined as mid-sized shares.
Last year, Hanmi Pharmaceutical clinched six licensing-out deals and collaboration projects worth a combined 7.6 trillion won.
The South Korean company has bagged a series of deals to license its pipeline products and collaborative research and development on early treatments for lung cancer and diabetes.
Founded in 1973, Hanmi spent 187 billion won on research and development last year, up 23 percent from a year earlier, it added.
In contrast, Daewoo Shipbuilding & Marine Engineering Co. slipped to become a mid-sized share in terms of market capitalization over the cited period. The company inked a record 5.5 trillion won in net loss last year.
colin@yna.co.kr
(END)
-
1 For veteran idol U-know Yunho, it's all about giving his best
-
2 (URGENT) Biden says America will repair alliances
-
3 S. Korea's military strength 6th in world, N. Korea at 28th: report
-
4 (profile) Liberal, press-friendly lawmaker tapped as culture minister
-
5 K-pop celebs a growing force for tourism in pandemic-hit S. Korea
-
1 (URGENT) Biden says America will repair alliances
-
2 S. Korea's military strength 6th in world, N. Korea at 28th: report
-
3 For veteran idol U-know Yunho, it's all about giving his best
-
4 'Gangnam Style' star Psy celebrates 20-year career anniversary
-
5 (profile) Liberal, press-friendly lawmaker tapped as culture minister
-
1 New virus cases under 400 again; alert in place against potential upticks
-
2 Pfizer to submit application for COVID-19 vaccine approval by end-Jan.
-
3 (2nd LD) Moon vows close cooperation with Biden for Korea peace process
-
4 Defense ministry vows push for regular inter-Korean military talks, swifter OPCON transfer
-
5 Two accomplices in online sex abuse ring sentenced to 15, 11 years in prison